Advances in the prevention and management of perioperative hypothermia in patients with gastrointestinal cancer
10.3781/j.issn.1000-7431.2024.2405-0251
- VernacularTitle:胃肠肿瘤患者围术期低体温的预防管理进展
- Author:
Xue WANG
1
;
Shen LIU
;
Fei YANG
;
Fan YU
;
Weiying ZHANG
Author Information
1. 同济大学医学院,上海 200092;上海交通大学医学院附属仁济医院护理部,上海 200127
- Publication Type:Journal Article
- Keywords:
Gastrointestinal tumor;
Perioperative hypothermia;
Prevention and management
- From:
Tumor
2024;44(7):793-799
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of gastrointestinal tumors has been increasing year by year,and surgical treatment remains the primary therapeutic approach.Perioperative hypothermia is one of the common complications in gastrointestinal tumor surgery,severely impacting patients'postoperative recovery.Perioperative hypothermia in patients with gastrointestinal tumors can lead to increased blood loss,delayed emergence from anesthesia,postoperative wound infections,gastroparesis,and intestinal paralysis,among other adverse outcomes.Therefore,effective preventive strategies are particularly important.Currently,a variety of intervention measures are employed to prevent perioperative hypothermia,including risk assessment,temperature measurement,pre-warming,passive warming,increasing environmental temperature,active warming,combined warming,and pharmacological interventions for thermoregulation.This review aims to explore the advances in the prevention and management of perioperative hypothermia in patients with gastrointestinal tumors,with the intention of raising medical staff's awareness of hypothermia protection,optimizing perioperative nursing processes,reducing the incidence of hypothermia,improving patients'postoperative recovery quality,decreasing the consumption of medical resources,and enhancing overall treatment outcomes.This study provides a theoretical basis and practical guidance for clinical nursing practice and contributes to the advancement of prevention and management of perioperative hypothermia in patients with gastrointestinal tumors.